Form D · Other
Canafarma Hemp Products Corp.
Vancouver, A1 · CIK 0001806160
Offering snapshot reported Jul 2, 2020 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 24, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2020 | Initial | $0 | No comparison | 0 | SEC filing |
| Mar 10, 2020 | Initial | $0 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-370130
Source: Form D, filed Jul 2, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank V. Barone | Executive |
| Sean Chipman | Executive |
| Kirill Chumenko | Executive |
| Merdan Gurbanov | Director |
| David Lonsdale | Executive, Promoter |
| Uri Mermelstein | Director |
| Vitaliy Snagovsky | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2080 777 Hornby Street
Vancouver, A1, V6Z 1S4
Vancouver, A1, V6Z 1S4